内生性乙醇与非酒精性脂肪性肝病研究进展*

doi:10.3969/j.issn.1672-5069.2016.01.032

Abstract

Abstract: Similar pathologic characteristics between non–alcoholic fatty liver disease and alcoholic liver disease presents a new direction for the hepatologists worldwide that endogenous alcohol may play important role in the development of non–alcoholic fatty liver disease. The closed relationship among endogenous alcohol and liver,intestine,intestinal flora and non–alcoholic fatty liver disease provides a new sight to explain the pathogenesis of non–alcoholic fatty liver diseases.

Key words: Non–alcoholic fatty liver diseases, Endogenous alcohol, Intestinal flora

He Chongxin, Xu Zhengjie, Fan Jiangao. Endogenous alcohol in non–alcoholic fatty liver disease[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 109-112.

References

[1] McManus IR,Contag AO,Olson RE. Characterization of endogenous ethanol in the mammal. Science,1960,131（3393）：102-103.
[2] You M,Fischer M,Deeg MA,et al. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element–binding protein（SREBP）. J Biol Chem,2002,277（32）：29342–29347.
[3] Yu S,Rao S,Reddy JK. Peroxisome proliferator–activated receptors,fatty acid oxidation,steatohepatitis and hepatocarcinogenesis. Curr Mol Med,2003,3（6）：561–572.
[4] 李慧莉,李秀敏. 乙醉诱导肝损伤作用机制概述. 中国药师, 2008,11（9）：1114–1116.
[5] Kwon HJ,Won YS,Park O,et al. Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice. Hepatology,2014,60（1）：146–157.
[6] Ladkin RG,Davies JN. Rupture of the stomach in an African child. Br Med J,1948,1（4552）：644.
[7] Jansson–Nettelbladt E,Meurling S,Petrini B,et al. Endogenous ethanol fermentation in a child with short bowel syndrome. Acta paediatrica,2003,95（4）：502–504.
[8] Spinucci G,Guidetti M,Lanzoni E,et al. Endogenous ethanol production in a patient with chronic intestinal pseudo–obstruction and small intestinal bacterial overgrowth. Eur J Gastroenterol Hepatol,2006,18（7）：799–802.
[9] American Gastroenterological Association Medical Position Statement：Guidelines for the evaluation and management of chronic diarrhea management of chronic diarrhea. Gastroenterology,1999,6（116）：1461–1463.
[10] Hauge T,Persson J,Danielsson D. Mucosal bacterial growth in the upper gastrointestinal tract in alcoholics（heavy drinkers）. Digestion,1997,58（6）：591–595.
[11] Gabbard SL,Lacy BE,Levine GM,et al. The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Dig Dis Sci,2014,59（3）：638–644.
[12] Cope K,Risby T,Diehl AM. Increased gastrointestinal ethanol production in obese mice：implications for fatty liver disease pathogenesis. Gastroenterology,2000,119（5）：1340–1347.
[13] Rao RK,Seth A,Sheth P. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol, 2004,286（6）：G881–G884.
[14] Maier A,Bode C,Fritz P,et al. Effects of chronic alcohol abuse on duodenal mononuclear cells in man. Dig Dis Sci,1999,44（4）：691–696.
[15] Chen P,Torralba M,Tan J,et al. Supplementation of saturated long–chain fatty acids maintains intestinal eubiosis and reduces ethanol–induced liver injury in mice. Gastroenterology,2015,148（1）：203–214.
[16] Qin J,Li R,Raes J,et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature,2010,464（7285）：59–65.
[17] Nicholson JK,Holmes E,Kinross J,et al. Host–gut microbiota metabolic interactions. Science,2012,336（6086）：1262–1267.
[18] Moschen AR,Kaser S,Tilg H. Non–alcoholic steatohepatitis：a microbiota–driven disease. Trends Endocrinol Metab,2013,24（11）：537–545.
[19] Turnbaugh PJ,Ley RE,Mahowald MA,et al. An obesity–associated gut microbiome with increased capacity for energy harvest. Nature,2006,444（7122）：1027–1031.
[20] Ley RE,Turnbaugh PJ,Klein S,et al. Microbial ecology：Human gut microbes associated with obesity. Nature,2006,444（7122）：1022–1023.
[21] Salekzamani Y,Shirmohammadi A,Rahbar M,et al. Association between human body composition and periodontal disease. ISRN Dent,2011,2011（86）：38-47.
[22] Machado MV,Cortez–Pinto H. Gut microbiota and nonalcoholic fatty liver disease. Ann Hepatol,2012,11（4）：440–449.
[23] Cani PD,Bibiloni R,Knauf C,et al. Changes in gut microbiota control metabolic endotoxemia–induced inflammation in high–fat diet–induced obesity and diabetes in mice. Diabetes,2008,57（6）：1470–1481.
[24] Membrez M,Blancher F,Jaquet M,et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J,2008,22（7）：2416–2426.
[25] Aron–Wisnewsky J,Gaborit B,Dutour A,et al. Gut microbiota and non–alcoholic fatty liver disease：new insights. Clin Microbiol Infect,2013,19（4）：338–348.
[26] Lirussi F,Mastropasqua E,Orando S,et al. Probiotics for non–alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev,2007,32（1）：D5165.
[27] Ritze Y,Bardos G,Claus A,et al. Lactobacillus rhamnosus GG protects against non–alcoholic fatty liver disease in mice. PLoS One,2014,9（1）：e80169.
[28] Cope K,Risby T,Diehl AM. Increased gastrointestinal ethanol production in obese mice：implications for fatty liver disease pathogenesis. Gastroenterology,2000,119（5）：1340–1347.
[29] Nair S,Cope K,Risby TH,et al. Obesity and female gender increase breath ethanol concentration： potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol, 2001,96（4）：1200–1204.
[30] Volynets V,Kuper MA,Strahl S,et al. Nutrition,intestinal permeability,and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease（NAFLD）. Dig Dis Sci,2012,57（7）：1932–1941.
[31] Zhu L,Baker SS,Gill C,et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis（NASH）patients：a connection between endogenous alcohol and NASH. Hepatology, 2013,57（2）：601–609.
[32] Baker SS,Baker RD,Liu W,et al. Role of alcohol metabolism in non–alcoholic steatohepatitis. PLoS One,2010,5（3）：e9570.
[33] de Medeiros IC,de Lima JG. Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease?–A mechanistic hypothesis. Med Hypotheses, 2015,[ahead of print].
[34] Frantz JC,McCallum RE. Growth yields and fermentation balance of Bacteroides fragilis cultured in glucose–enriched medium. J Bacteriol,1979,3（137）：1263–1270.
[35] Amaretti A,Bernardi T,Tamburini E,et al. Kinetics and metabolism of Bifidobacterium adolescentis MB 239 growing on glucose,galactose,lactose, and galactooligosaccharides. Appl Environ Microbol,2007,11（73）：3637–3644.
[36] Weimer PJ,Zeikus JG. Fermentation of cellulose and cellobiose by Clostridium thermocellum in the absence and presence of Methanobacterium thermoautotrophicum. Appl Environ Microbol, 1977,2（33）：289–297.
[37] Engstler AJ,Aumiller T,Degen C,et al. Insulin resistance alters hepatic ethanol metabolism：studies in mice and children with non–alcoholic fatty liver disease. Gut,2015,10（11）：30-38.
[38] Simic M,Ajdukovic N,Veselinovic I,et al. Endogenous ethanol production in patients with diabetes mellitus as a medicolegal problem. Forensic Sci Int,2012,216（1–3）：97–100.

Endogenous alcohol in non–alcoholic fatty liver disease

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 7

Recommended Articles

Metrics

Comments

[1]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[2]	Zhang Xuan, Tang Xiaoyun, Tang Chunyin, et al. Effect of Chinese herbal medicine on intestinal microflora in mice with D-galactosamine/LPS-induced acute liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 478-481.
[3]	Yan Xisheng, Li Wei, Wang Jian, et al. Changes of serum cytokines and intestinal flora distribution in patients with alcoholic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 518-521.
[4]	Wang Ming, Zhang Shu, Li Ming, Wen Jun, Zheng Zhenjiang. Comparative study of serum and fecal HBV DNA in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 176-179.
[5]	Zheng Tingting, Jiang Shanshan, Fang Zhongliao, et al.. Changes of intestinal flora in patients with hepatitis B viral infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 899-902.
[6]	Liang Sufang, Xu Lin. Intestinal dysbacteriosis in patients with hapatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 245-248.
[7]	Chen Xiaoyu, Yang Changqing. Progress in the pathogenesis of liver fibrosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 121-124.